SEOUL, Sept. 2 (Korea Bizwire) — A South Korean research team revealed that people who have been infected with coronavirus can develop enough antibodies with a single shot of vaccine, which normally requires two shots. A research team from Myongji Hospital studied the developments of antibodies and other side effects of two medical staff who [...]
SEOUL, Aug. 30 (Korea Bizwire) — South Korean drugmaker SK Bioscience Co. said Monday it has begun the phase three clinical trial of its COVID-19 vaccine candidate. GBP510, under development by SK Bioscience, a unit of the country’s No. 2 family-controlled conglomerate SK Group, was administered to the first participant. It comes nearly three weeks [...]
SEOUL, Aug. 23 (Korea Bizwire) — South Korean biopharmaceutical firm Samsung Bioepis Co. said Monday it has won approval from European authorities for the sale of its ophthalmology biosimilar, Byooviz. The European Commission granted the marketing authorization on ranibizumab biosimilar, previously known as SB11, which references Swiss pharmaceutical giant Novartis’ blockbuster medication Lucentis. It is [...]
SEOUL, Aug. 19 (Korea Bizwire) — Medical experts are divided over the government’s decision to alleviate age requirements for the AstraZeneca’s COVID-19 vaccine, which was originally available only to those over 50 years of age. The Korea Disease Control and Prevention Agency introduced new measures last week that allow citizens over 30 years of age [...]
SEOUL, Aug. 17 (Korea Bizwire) — A recent study found that compared to people without rheumatism, individuals suffering from rheumatism have a higher risk of being infected with COVID-19 and once they get infected, they are more likely to develop severe symptoms. Based on data from the National Health Insurance Service, a research team from [...]
SEOUL, Aug. 13 (Korea Bizwire) – South Korea on Friday allowed administration of leftover AstraZenenca COVID-19 vaccine doses to people aged 30 and over amid concerns over unused vaccines being wasted, health authorities said. The country had so far only allowed vaccines manufactured by British-Swedish pharmaceutical giant AstraZeneca and Oxford University to people aged 50 [...]
SEOUL, Aug. 13 (Korea Bizwire) — The number of individuals in South Korea registering their decision to end life-sustaining treatment has reached the 1 million milestone. The Ministry of Health and Welfare said that in the three years and six months since patients were first allowed to decide upon life-sustaining treatment, the number of submissions [...]
SEOUL, Aug. 11 (Korea Bizwire) — South Korea is suffering from the worst wave of the coronavirus pandemic despite tough restrictions across the country as more contagious variants are fast spreading amid the lagging vaccination drive, putting the country’s virus battle in jeopardy. New cases have rapidly risen across the nation since early July, surging [...]
SEOUL, Aug. 10 (Korea Bizwire) – South Korean drugmaker SK Bioscience Co. has won an approval to conduct the phase three clinical trial of its COVID-19 vaccine candidate, drug authorities said Tuesday. The Ministry of Food and Drug Safety said GBP510, under development by SK Bioscience, a unit of the country’s No. 2 family-controlled conglomerate [...]
SEOUL, Aug. 9 (Korea Bizwire) — Moderna Inc. has notified South Korean health authorities that it will supply less than half of the 8.5 million doses of its COVID-19 vaccine planned for August, Seoul officials said Monday, spawning concerns that the country’s vaccine rollout may hit a snag. The U.S. vaccine maker said some problems [...]